SMPD3 and Duchenne muscular dystrophy: Furthermore, the signaling pathways modulated by the nSMase2/Smpd3 protein might be novel therapeutic targets for DMD via the regulation of the expression levels of exosomal miRNAs using this nSMase2/Smpd3 protein.